EC5026

• Description:

  EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators. EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids. Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  405.39

• Molecular Formula:

  C18H23F4N3O3

• Notes:

  Research use only, not for human use.

• Receptor:

  SEH

• CAS Number:

  1809885-32-2